GlassScriptPhysician profile
Daniel M Salcedo
NPI 1346220803
$19,087.60
in general payments reported to CMS, 2019-2025
52 companies · $685 in 2025
The $685 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,464 · 2020: $2,011 · 2021: $2,719 · 2022: $2,533 · 2023: $1,571 · 2024: $5,104 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,784 · Travel and Lodging: $2,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,783.54 |
| Travel and Lodging | $2,577.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,836.71 | 2019-2025 | Octrode, Ionicrf, Infinity |
| Boston Scientific Corporation | $2,112.82 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $2,038.10 | 2019-2024 | Senza |
| Si-Bone, INC. | $1,728.09 | 2019-2024 | |
| Spinal Simplicity, LLC | $1,439.18 | 2024 | Ha Minuteman G3-R, Liberty Si |
| Curonix LLC | $1,044.99 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $748.86 | 2019-2025 | Xtampza, Belbuca |
| Spr Therapeutics, INC | $608.35 | 2022-2025 | Sprint Pns System |
| Mdd US Operations, LLC | $551.73 | 2019-2025 | Gocovri |
| Medtronic, INC. | $311.03 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $289.82 | 2024-2025 | |
| Abbvie INC. | $275.42 | 2021-2023 | Botox, Qulipta |
| Biohaven Pharmaceutical Holding Company LTD. | $252.83 | 2022 | |
| Vertos Medical, INC. | $237.11 | 2022-2024 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $221.46 | 2024-2025 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Salcedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.